Moderna (MRNA) stock analysis and fair value
MRNA · NASDAQ · Healthcare
240,84 US$
▲ +6,15%
Cerne score
36out of 100
Weak
- Quality38
- Growth72
- Financial strength50
- Valuation0
In 30 seconds
The business. Healthcare. Sells 1,9 B US$ a year, but is losing money.
The price. No profit over the last 12 months: you can't tell if it's cheap based on earnings.
Strength. Passes 3 of 7 quality checks and has more cash than debt.
MRNA fair value
Work out what the stock is worth with your own growth, margin and return assumptions. Free during launch.
See the fair valueModerna key numbers
- Market cap
- 96,2 B US$
- Revenue growth
- 37,8%
- a year, over 9 years
- Profit margin
- -145,2%
- Quality checks
- 3/7
Fiscal 2025 financials, as filed with the SEC.
See everything about MRNA on Cerne
- Fair value with your own assumptions
- Every analyst and price target
- 10 years of financials in simple charts
- Dividends, earnings and ratios vs. the sector